# Neoadjuvant Treatment of Colon Cancer

> **NCT01108107** · PHASE2 · COMPLETED · sponsor: **Vejle Hospital** · enrollment: 76 (actual)

## Conditions studied

- Colon Cancer

## Interventions

- **DRUG:** Oxaliplatin
- **DRUG:** Capecitabine
- **DRUG:** Oxaliplatin
- **DRUG:** Capecitabine
- **BIOLOGICAL:** Panitumumab

## Key facts

- **NCT ID:** NCT01108107
- **Lead sponsor:** Vejle Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-04
- **Primary completion:** 2013-09
- **Final completion:** 2015-03
- **Target enrollment:** 76 (ACTUAL)
- **Last updated:** 2015-05-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01108107

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01108107, "Neoadjuvant Treatment of Colon Cancer". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01108107. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*